These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation. Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883 [TBL] [Abstract][Full Text] [Related]
43. Association of F11R polymorphisms and gene expression with primary Sjögren's syndrome patients. Fang TJ; Li RN; Lin YZ; Lin CH; Tseng CC; Sung WY; Ou TT; Wu CC; Yen JH Int J Rheum Dis; 2021 May; 24(5):681-686. PubMed ID: 33780157 [TBL] [Abstract][Full Text] [Related]
45. Study of clinical factors, focus score, lymphocyte type and NF-κB pathway in Sjögren's syndrome. Ono J; Toya S; Ogura I; Okada Y Odontology; 2023 Jan; 111(1):207-216. PubMed ID: 35915313 [TBL] [Abstract][Full Text] [Related]
46. TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren's syndrome patients. Fletes-Rayas AL; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Oregon-Romero E Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323176 [TBL] [Abstract][Full Text] [Related]
47. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20. Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442 [TBL] [Abstract][Full Text] [Related]
48. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study. Baldini C; Santini E; Rossi C; Donati V; Solini A J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820 [TBL] [Abstract][Full Text] [Related]
49. Lymphoma development in Sjögren's syndrome: novel p53 mutations. Tapinos NI; Polihronis M; Moutsopoulos HM Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275 [TBL] [Abstract][Full Text] [Related]
50. Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus. Odqvist L; Jevnikar Z; Riise R; Öberg L; Rhedin M; Leonard D; Yrlid L; Jackson S; Mattsson J; Nanda S; Cohen P; Knebel A; Arthur S; Thörn K; Svenungsson E; Jönsen A; Gunnarsson I; Tandre K; Alexsson A; Kastbom A; Rantapää-Dahlqvist S; Eloranta ML; Syvänen AC; Bengtsson A; Johansson P; Sandling JK; Sjöwall C; Rönnblom L; Collins B; Vaarala O Ann Rheum Dis; 2019 Oct; 78(10):1363-1370. PubMed ID: 31300459 [TBL] [Abstract][Full Text] [Related]
51. Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores. Vlachogiannis NI; Nezos A; Tzioufas AG; Koutsilieris M; Moutsopoulos HM; Mavragani CP Clin Immunol; 2016 Dec; 173():157-160. PubMed ID: 27810512 [TBL] [Abstract][Full Text] [Related]
52. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. Fabris M; Dolcetti R; Pasini E; Quartuccio L; Pontarini E; Salvin S; Ponzoni M; Scott CA; De Vita S Clin Exp Rheumatol; 2014; 32(1):61-5. PubMed ID: 24447326 [TBL] [Abstract][Full Text] [Related]
53. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter. Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914 [TBL] [Abstract][Full Text] [Related]
54. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort. Márka M; Bessenyei B; Zeher M; Semsei I Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644 [TBL] [Abstract][Full Text] [Related]
55. rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population. Xu E; Cao H; Lin L; Liu H PLoS One; 2017; 12(4):e0176471. PubMed ID: 28448618 [TBL] [Abstract][Full Text] [Related]
56. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma. Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001 [TBL] [Abstract][Full Text] [Related]
57. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome. Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802 [TBL] [Abstract][Full Text] [Related]
58. Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease. Kim YH; Li Z; Cui L; Li Y; Yoon HJ; Choi W; Lee JB; Liu Z; Yoon KC Am J Ophthalmol; 2019 Apr; 200():150-160. PubMed ID: 30653959 [TBL] [Abstract][Full Text] [Related]
59. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Ramos-Casals M; Cervera R; Font J; García-Carrasco M; Espinosa G; Reino S; Pallarés L; Ingelmo M Lupus; 1998; 7(3):202-6. PubMed ID: 9607645 [TBL] [Abstract][Full Text] [Related]
60. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]